Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REPRISE III: Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System - Randomized Clinical Evaluation

NCT02202434 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT02202434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02202434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REPRISE III: Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System - Randomized Clinical Evaluation
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Terminated
Start date
September 22, 2014
Completion date
May 21, 2021
Enrollment
1,425 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis